The implications of dirty drug synthesis and medication compounding processes are dangerous and real.
Deleted testing results are a red flag; however, keep in mind that lack of evidence to the contrary is not evidence of the positive. I see this more as regulation being used to limit international competition than anything promoting general human welfare.
If the reason they're so ill suited for public discussion is the half truths and misconceptions, statements like this one aren't doing anything to help:
> once your precious baby gets born with no legs your stance will be a tad different
It is even a truism to say that medicine for pregnant women (when not relating to the pregnancy itself) is far behind "normal" medicine, as for most treatments it is not known what effect they'll have on the embryo, or if there will be interactions between the pregnancy and the treatment. Of course there is also a number of treatments that can't be used because they're known to be harmful, but not nearly as many. This crisis is one of the main reasons for this.
But what caused babies with no legs: The softenon/thalomide disaster.
Here's the full story: https://en.wikipedia.org/wiki/Thalidomide#Birth_defects_cris... More photos illustrating exactly what went wrong can be found here: https://en.wikipedia.org/wiki/Phocomelia
The scary part is that it was a problem relating to the chirality of the molecule used. Very few chemical tests of the molecule would have even revealed that there were two kinds of the molecule, and there was no good reason to assume one would cause deformed babies. In other words: this was extremely likely (and sadly) an honest mistake. 20000 deformed babies were born, about half survived (I went to school with a very cute and smart one). One enantiomer causes babies with missing appendages, one does not. Both help against a number of cancers, various serious diseases and there is some use as a sedative and it helps against morning sickness during pregnancy.
Getting the chirality right is bloody hard, even for people with advanced chemistry degrees (especially getting to the required purity).
This disaster is also well known for being one of the main reasons our current pharma regime is what it is.
growing up with Germans of that generation makes it likely to encounter the effects of less regulated pharma first hand. the US was protected from it, which might explain the more prevalent ignorance here.
like good fire protection lulling you into the belief that fire never happens. so lets splash around in gasoline, because freedom and conspiracies by big firefighters.
Really made me think of the Zoolander movie : https://www.youtube.com/watch?v=ZnZ2XdqGZWU#t=2m16s
To do this it costs lab space, it costs machines that easily go in the millions, it costs sweat and tears of scientists, it takes the lives of many generations of scientists sometimes. The stakes are already high for those who take on these projects. Already, we have a problem with PhDs in the health sciences field making shit money. You want to further discourage them into going in this field by denying them what little they get now? So that they rather make easy money serving you ads based on the information they've gotten from observing your habits?
exactly the same as in tech - founders reap the big rewards, individual coders less so.
http://pipeline.corante.com/archives/2010/11/04/where_drugs_...
58% from pharmaceutical companies.
18% from biotech companies..
16% from universities, transferred to biotech.
8% from universities, transferred to pharma.
Pharma and biotech companies do develop some drugs themselves, but the majority model is for a start-up to form around a single drug, and if it looks promising a big player buys them up to finish testing and then market it. If the drug looks promising the company is killed.
Venture capital is basically doing the job of drug discovery.
But I suspect the reality is different. I can imagine a couple of reasons for low salaries: Big Pharma would like nothing more than pay its personnel decently, but they're barely breaking even. Alternatively, the ratio between PhDs and jobs available doesn't work in the favour of PhDs. In which case, Big Pharma making even more money would translate into additional mansions for C-level executives, not better salaries for PhDs.
Which explanation do you feel is the most likely?
That said, yes, I think the health sector should be state-run and not operate with a profit motive, but whether or not you agree or with this idea doesn't change the fact that your comparison is flawed.
Good. An imperfect (with the odd frog), but cheap, system that can save thousands of lives is perfectly acceptable to me.